Cathie Wood Recursion Pharmaceuticals, Inc. Transaction History
Ark Investment Management LLC
- $14 Billion
- Q1 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 24,587,561 shares of RXRX stock, worth $232 Million. This represents 1.75% of its overall portfolio holdings.
Number of Shares
24,587,561
Previous 20,654,287
19.04%
Holding current value
$232 Million
Previous $204 Million
20.37%
% of portfolio
1.75%
Previous 1.22%
Shares
12 transactions
Others Institutions Holding RXRX
# of Institutions
257Shares Held
191MCall Options Held
787KPut Options Held
1.52M-
Baillie Gifford & CO24.1MShares$227 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$151 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$116 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V710.4MShares$98 Million100.0% of portfolio
-
Nikko Asset Management Americas, Inc.10.4MShares$97.6 Million1.03% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.7B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...